Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton Jelly Originated Mesenchymal Stem Cell in Treatment of Knee Osteoarthritis
NCT04313894Phase 2Unknown
- Sponsor
- Erciyes University
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of wharton jelly originated mesenchymal stem cell in knee osteoarthritis (OA), sponsored by Erciyes University. Status: unknown.
02
Drugs
wharton jelly originated mesenchymal stem cell
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04313894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313894.